Influence of type of starch and feeding management

Affect of kind of starch and feeding administration on glycaemic management in diabetic canine

  • The current research evaluated the consequences of two diets with completely different starch sources and two feeding strategies on the glycaemic management in canine with diabetes mellitus. The diets had related nutrient contents (40% starch and 16% dietary fibre), one formulated with 46% of damaged rice and the opposite with 42% sorghum and 10% lentils (as-fed).
  • Ten client-owned diabetic canine had been fed with every weight loss plan for two months, in a crossover design. 5 canine obtained NPH human insulin and meals each 12 h (feeding technique 1), and the opposite 5 obtained insulin each 12 h however had been fed 3 times a day (feeding technique 2). In feeding technique 2, morning insulin was larger than the night dose and canine obtained the second meal after Four to five h of the morning insulin and meal.
  • Parameters evaluated included insulin dosage, 12- and 8-h glycaemic curves, full blood rely, biochemical profile and urinalysis. Glycaemic curves had been analysed by ANOVA with repeated measures. Glycaemic management parameters (fasting, imply, minimal and most glycaemia and serum fructosamine) and glucose space underneath the curve (AUC) had been calculated and analysed by paired t check (p < 0.05). In feeding technique 1, canine fed the sorghum-based weight loss plan offered decrease imply (p = 0.04) and minimal blood glucose concentrations (p = 0.03), and an inclination to decrease most blood glucose (p = 0.06) and glucose AUC (p = 0.08) than when fed the rice-based weight loss plan.
  • When meals was offered twice a day, the ingestion of the rice-based weight loss plan resulted in larger post-prandial glucose response than the weight loss plan with sorghum and lentil. In feeding technique 2, there was no impact of weight loss plan on the assessed parameters (p > 0.05).
  • No variations in insulin dosage had been noticed between teams or feeding strategies (p > 0.05). Offering two meals a day adopted by insulin administration related to the sorghum- and lentil-based weight loss plan improved glycaemic management in diabetic canine.
insuline-medical
insuline-medical

RRAD Antibody

1-CSB-PA248209
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100

RRAD Antibody

1-CSB-PA779820
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

RRAD Antibody

GWB-MU399C 50ug Ask for price

RRAD Antibody

GWB-MU400D 50ug Ask for price

RRAD Antibody

R34275-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Ras-related associated with diabetes

Polyclonal RRAD Antibody

APR05556G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications:

OAAF03734-100UG - RRAD Antibody

OAAF03734-100UG 100ug
EUR 329

RRAD Conjugated Antibody

C37229 100ul
EUR 476.4

GTP-Binding Protein RAD (RRAD) Antibody

abx432011-200ul 200 ul
EUR 460.8

GTP-binding protein RAD (RRAD) Antibody

20-abx324872
  • Ask for price
  • Ask for price
  • 100 ug
  • 50 ug

GTP-binding protein RAD (RRAD) Antibody

abx332370-100ul 100 ul
EUR 510

GTP-binding protein RAD (RRAD) Antibody

20-abx214509
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

GTP-binding protein RAD (RRAD) Antibody

20-abx241706
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

GTP-Binding Protein RAD (RRAD) Antibody

20-abx008742
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

GTP-binding protein RAD (RRAD) Antibody

abx241706-96tests 96 tests
EUR 250

GTP-binding protein RAD (RRAD) Antibody

abx214509-100tests 100 tests
EUR 350

GTP-binding protein RAD (RRAD) Antibody

abx214509-200tests 200 tests Ask for price

GTP-binding protein RAD (RRAD) Antibody

abx214509-20tests 20 tests
EUR 250

GTP-binding protein RAD (RRAD) Antibody

abx324872-100g 100 µg
EUR 250

GTP-binding protein RAD (RRAD) Antibody

abx324872-50g 50 µg
EUR 187.5

GTP-Binding Protein RAD (RRAD) Antibody

abx432011-100g 100 µg
EUR 387.5

RRAD Rabbit Polyclonal Antibody

E10G04435 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

RRAD Rabbit Polyclonal Antibody

E10G11330 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

ARP56566_P050-25UL - RRAD Antibody - middle region

ARP56566_P050-25UL 25ul
EUR 99

ARP56567_P050-25UL - RRAD Antibody - middle region

ARP56567_P050-25UL 25ul
EUR 99

OAEB02919-100UG - RRAD Antibody - middle region

OAEB02919-100UG 100ug
EUR 349

OASG06195-100UL - RRAD Antibody - middle region

OASG06195-100UL 100ul
EUR 239

ARP56566_P050 - RRAD antibody - middle region (ARP56566_P050)

ARP56566_P050 100ul
EUR 389

ARP56567_P050 - RRAD antibody - middle region (ARP56567_P050)

ARP56567_P050 100ul
EUR 389

Rrad/ Rat Rrad ELISA Kit

ELI-14921r 96 Tests
EUR 1063.2

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx237237-100ug 100 ug
EUR 661.2

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx122938-100ug 100 ug
EUR 469.2

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx237237-100g 100 µg
EUR 350

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx122938-100l 100 µl Ask for price

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx122938-20l 20 µl
EUR 337.5

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx122938-50l 50 µl Ask for price

Polyclonal RRAD (aa36-48) Antibody (internal region)

APG00807G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications:

RRAD siRNA

20-abx932133
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

RRAD Peptide

43-008P 0.1 mg
EUR 405.6
Description: RRAD Peptide

RRAD Blocking Peptide

33R-10070 100 ug
EUR 119
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798

RRAD Blocking Peptide

33R-4793 100 ug
EUR 119
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797

RRAD Blocking Peptide

20-abx063234
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad)

MG204351 10 µg Ask for price

Rrad (untagged) - Mouse Ras-related associated with diabetes (Rrad), (10ug)

MC203288 10 µg Ask for price

RRAD ELISA KIT|Human

EF005507 96 Tests
EUR 826.8

Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad)

MR204351 10 µg Ask for price

Human RRAD shRNA Plasmid

20-abx954199
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Rrad (untagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug)

RN208148 10 µg Ask for price

RRAD Recombinant Protein (Rat)

RP226925 100 ug Ask for price

RRAD Recombinant Protein (Human)

RP095493 100 ug Ask for price

RRAD Recombinant Protein (Mouse)

RP169340 100 ug Ask for price

Rrad ORF Vector (Rat) (pORF)

ORF075643 1.0 ug DNA
EUR 607.2

RRAD (untagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 1

SC322965 10 µg Ask for price

RRAD (untagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 2

SC117559 10 µg Ask for price

Rrad ORF Vector (Mouse) (pORF)

ORF056448 1.0 ug DNA
EUR 607.2

RRAD ORF Vector (Human) (pORF)

ORF031832 1.0 ug DNA
EUR 486

Human RRAD knockout cell line

ABC-KH13200 1 vial Ask for price
Description: Human RRAD knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

RRAD (GFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 2

RG202927 10 µg Ask for price

RRAD (GFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 1

RG225433 10 µg Ask for price

Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug)

RR208148 10 µg Ask for price

Human RRAD knockdown cell line

ABC-KD13200 1 vial Ask for price
Description: Human RRAD knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human RRAD Protein Lysate 20ug

IHURRADPLLY20UG each
EUR 213
Description: Human RRAD Protein Lysate 20ug

Lenti ORF clone of Rrad (mGFP-tagged) - Mouse Ras-related associated with diabetes (Rrad)

MR204351L4 10 µg Ask for price

OCOA18635-20UG - RRAD Protein Lysate

OCOA18635-20UG 20ug
EUR 169

OCOA13236-20UG - RRAD Protein Lysate

OCOA13236-20UG 20ug
EUR 169

RRAD (Myc-DDK-tagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 2

RC202927 10 µg Ask for price

RRAD (Myc-DDK-tagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 1

RC225433 10 µg Ask for price

Lenti ORF clone of Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad)

MR204351L3 10 µg Ask for price

Lenti ORF particles, Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL

MR204351L4V 200 µl Ask for price

Rrad sgRNA CRISPR Lentivector set (Rat)

K7052701 3 x 1.0 ug
EUR 406.8

Lenti ORF particles, Rrad (GFP-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL

RR208148L4V 200 µl Ask for price

Lenti ORF clone of Rrad (mGFP-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug)

RR208148L4 10 µg Ask for price

RRAD 3'UTR GFP Stable Cell Line

TU072380 1.0 ml
EUR 1672.8

Rrad 3'UTR GFP Stable Cell Line

TU269725 1.0 ml Ask for price

Rrad 3'UTR GFP Stable Cell Line

TU168183 1.0 ml Ask for price

RRAD sgRNA CRISPR Lentivector set (Human)

K2069901 3 x 1.0 ug
EUR 406.8

Rrad sgRNA CRISPR Lentivector set (Mouse)

K3480701 3 x 1.0 ug
EUR 406.8

Lenti ORF particles, Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL

MR204351L3V 200 µl Ask for price

AAP56566-100UG - RRAD Peptide - middle region

AAP56566-100UG 100ug
EUR 99

AAP56567-100UG - RRAD Peptide - middle region

AAP56567-100UG 100ug
EUR 99

RRAD Protein Vector (Rat) (pPM-C-HA)

PV302572 500 ng
EUR 723.6

Lenti ORF particles, Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL

RR208148L3V 200 µl Ask for price

RRAD Protein Vector (Rat) (pPB-C-His)

PV302570 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPB-N-His)

PV302571 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPM-C-His)

PV302573 500 ng
EUR 723.6

Lenti ORF clone of Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug)

RR208148L3 10 µg Ask for price

RRAD Protein Vector (Mouse) (pPM-C-HA)

PV225792 500 ng
EUR 723.6

RRAD Protein Vector (Human) (pPM-C-HA)

PV127328 500 ng
EUR 662.4

RRAD Protein Vector (Mouse) (pPB-C-His)

PV225790 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPB-N-His)

PV225791 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPM-C-His)

PV225793 500 ng
EUR 723.6

RRAD Protein Vector (Human) (pPB-C-His)

PV127326 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPB-N-His)

PV127327 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPM-C-His)

PV127329 500 ng
EUR 662.4

Rrad 3'UTR Luciferase Stable Cell Line

TU118183 1.0 ml Ask for price

RRAD 3'UTR Luciferase Stable Cell Line

TU022380 1.0 ml
EUR 1672.8

Rrad 3'UTR Luciferase Stable Cell Line

TU219725 1.0 ml Ask for price

Rrad sgRNA CRISPR Lentivector (Rat) (Target 1)

K7052702 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 2)

K7052703 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 3)

K7052704 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 1)

K2069902 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 2)

K2069903 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 3)

K2069904 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3480702 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3480703 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3480704 1.0 ug DNA
EUR 184.8

Mouse GTP- binding protein RAD, Rrad ELISA KIT

ELI-14089m 96 Tests
EUR 1038

Human GTP- binding protein RAD, RRAD ELISA KIT

ELI-35549h 96 Tests
EUR 988.8

Rat GTP-binding protein RAD (RRAD) ELISA Kit

abx391893-96tests 96 tests
EUR 1093.2

Rat GTP-Binding Protein RAD (RRAD) ELISA Kit

abx391893-200g 200 µg
EUR 687.5

Associations between attainment of incentivized main care indicators and incident decrease limb amputation amongst these with kind 2 diabetes: a population-based historic cohort research

Introduction: England has invested significantly in diabetes care by way of such packages because the High quality and Outcomes Framework (QOF) and Nationwide Diabetes Audit (NDA). Associations between program indicators and scientific endpoints, similar to amputation, stay unclear. We examined associations between main care indicators and incident decrease limb amputation.

Analysis design and strategies: This population-based retrospective cohort research, spanning 2010-2017, was comprised of adults in England with kind 2 diabetes and no historical past of decrease limb amputation. Exposures at baseline (2010-2011) had been attainment of QOF glycated hemoglobin (HbA1c), blood stress and whole ldl cholesterol indicators, and variety of NDA processes accomplished.

Propensity rating matching was carried out and multivariable Cox proportional hazards fashions, adjusting for disease-related, comorbidity, way of life, and sociodemographic elements, had been fitted utilizing matched samples for every publicity.

Outcomes: 83 688 people from 330 English main care practices had been included. Imply follow-up was 3.9 (SD 2.0) years, and 521 (0.6%) minor or main amputations had been noticed (1.62 per 1000 person-years). HbA1c and ldl cholesterol indicator attainment had been related to significantly decrease dangers of minor or main amputation (adjusted HRs; 95% CIs) 0.61 (0.49 to 0.74; p<0.0001) and 0.67 (0.53 to 0.86; p=0.0017), respectively). No proof of affiliation between blood stress indicator attainment and amputation was noticed (adjusted HR 0.88 (0.73 to 1.06; p=0.1891)).

Considerably decrease amputation charges had been noticed amongst these finishing a larger variety of NDA care processes (adjusted HRs 0.45 (0.24 to 0.83; p=0.0106), 0.67 (0.47 to 0.97; p=0.0319), and 0.38 (0.20 to 0.70; p=0.0022) for comparisons of 4-6 vs 0-3, 7-9 vs 0-3, and 7-9 vs 4-6 processes, respectively). Outcomes for major-only amputations had been related for HbA1c and blood stress, although ldl cholesterol indicator attainment was non-significant.

Conclusions: Complete main care-based secondary prevention might supply appreciable safety in opposition to diabetes-related amputation. This has necessary implications for diabetes administration and medical decision-making for sufferers, in addition to kind 2 diabetes high quality enchancment packages.

 

The pattern-recognition molecule H-ficolin in relation to diabetic kidney illness, mortality, and cardiovascular occasions in kind 1 diabetes

H-ficolin acknowledges patterns on microorganisms and burdened cells and may activate the lectin pathway of the complement system. We aimed to evaluate H-ficolin in relation to the development of diabetic kidney illness (DKD), all-cause mortality, diabetes-related mortality, and cardiovascular occasions.

Occasion charges per 10-unit H-ficolin-increase had been in contrast in an observational follow-up of two,410 people with kind 1 diabetes from the FinnDiane Research. DKD development occurred in 400 people. The unadjusted hazard ratio (HR) for development was 1.29 (1.18-1.40) and 1.16 (1.05-1.29) after adjustment for diabetes length, intercourse, HbA1c, systolic blood stress, and smoking standing.

After including triglycerides to the mannequin, the HR decreased to 1.07 (0.97-1.18). In all, 486 people died, together with 268 deaths of cardiovascular causes and 192 deaths of problems to diabetes. HRs for all-cause mortality and cardiovascular mortality had been 1.13 (1.04-1.22) and 1.05 (0.93-1.17), respectively, in unadjusted analyses. These estimates misplaced statistical significance in adjusted fashions.

Nevertheless, the unadjusted HR for diabetes-related mortality was 1.19 (1.05-1.35) and 1.18 (1.02-1.37) with probably the most stringent adjustment stage. Our outcomes, due to this fact, point out that H-ficolin predicts diabetes-related mortality, however neither all-cause mortality nor deadly/non-fatal cardiovascular occasions. Moreover, H-ficolin is related to DKD development, nevertheless, not independently of the totally adjusted mannequin.

The worth of glycosylated hemoglobin within the prognosis of diabetic retinopathy: a scientific evaluate and Meta-analysis

 Goal: Glycosylated hemoglobin (HbA1c) has apparent scientific worth within the prognosis of diabetes, however the conclusions on the diagnostic worth of diabetic retinopathy (DR) should not constant. This research goals to comprehensively consider the accuracy of glycosylated hemoglobin within the prognosis of diabetic retinopathy by way of the meta-analysis of diagnostic checks.

Strategies: Cochrane Library, Embase, PubMed, Net of Science, China Nationwide Information Infrastructure (CNKI), China Wanfang Database, Chinese language Biomedical Literature Database (CBM) had been searched till November, 2020. The High quality Evaluation of Diagnostic Accuracy Research-2 (QUADAS-2) software was used to evaluate the standard of the included research. The pooled sensitivity, specificity, optimistic probability ratio (+LR), unfavourable probability ratio (-LR), diagnostic odds ratio (DOR) and areas underneath the receiver working attribute (ROC) curve had been calculated by Stata 15.Zero software program.

Outcomes: After screening, 18 high-quality papers had been included. The outcomes of meta-analysis confirmed that the mixed DOR = 18.19 (95% CI: 10.99-30.11), the sensitivity= 0.81 (95% CI): 0.75 ~ 0.87), specificity = 0.81 (95%CI: 0.72 ~ 0.87), +LR = 4.2 (95%CI: 2.95 ~ 6.00), -LR = 0.23 (95%CI: 0.17 ~ 0.31), and the world underneath the Abstract ROC curve was 0.88 (95%CI: 0.85 ~ 0.90).

Conclusion: The general accuracy of HbA1cC forin diagnosing diabetic retinopathy is sweet. As it’s extra secure than blood sugar and isn’t affected by meals, it might be an acceptable indicator for diabetic retinopathy.

Human Type I Diabetes PB Plasma

ABC-TC4264 1 vial Ask for price
Description: Type I Diabetes peripheral blood plasma is obtained by centrifugation of the Type I Diabetes PB. This product has a diminished number of cells and platelets. Fresh Diabetic Type I PB plasma is available upon request.

Human Type II Diabetes PB Plasma

ABC-TC4266 1 vial Ask for price
Description: Type II Diabetes peripheral blood plasma is obtained by centrifugation of the Type II Diabetes PB. This product has a diminished number of cells and platelets. Fresh Diabetic Type II PB plasma is available upon request.

HighQC™ Human IPS Cell (Type 2 Diabetes)

ABC-SC0005T 1 vial Ask for price
Description: Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be derived directly from adult somatic cells . The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPS cells, thus, hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells.

Single Donor Human Type II Diabetes Semen

IRHUSMSDIBTII1ML each
EUR 842
Description: Single Donor Human Type II Diabetes Semen

Single Donor Human Type I Diabetes Urine

IRHUURESDIBTI250ML each
EUR 1063
Description: Single Donor Human Type I Diabetes Urine

Single Donor Human Type I Diabetes Urine

IRHUURESDIBTI50ML each
EUR 439
Description: Single Donor Human Type I Diabetes Urine

Single Donor Human Type II Diabetes Urine

IRHUURESDIBTII250ML each
EUR 1063
Description: Single Donor Human Type II Diabetes Urine

Single Donor Human Type II Diabetes Urine

IRHUURESDIBTII50ML each
EUR 439
Description: Single Donor Human Type II Diabetes Urine

HighQC™ Human IPS Cell (Episomal/ Diabetes Type II/ Adipose)

ABC-SC0011T 1 vial Ask for price
Description: Gentaur offers human iPS cell lines derived from PBMCs, dermal fibroblasts, or adipose tissue of patients with Parkinson's Disease (PD) and Diabetes II. These iPS cells are established from a single clone and expanded in feeder-free conditions.

HighQC™ Human IPS Cell (IPSC From PBMC/ Diabetes Type II/ Episomal)

ABC-SC0009T 1 vial Ask for price
Description: Gentaur offers human iPS cell lines derived from PBMCs, dermal fibroblasts, or adipose tissue of patients with Parkinson's Disease (PD) and Diabetes II. These iPS cells are established from a single clone and expanded in feeder-free conditions.

Human Type I Diabetes Peripheral Blood Mononuclear Cells

ABC-TC4263 1 vial Ask for price
Description: Peripheral blood mononuclear cells are isolated from Type I Diabetes peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh Diabetic Type I PBMCs is available upon request.

Human Type II Diabetes Peripheral Blood Mononuclear Cells

ABC-TC4265 1 vial Ask for price
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays. A peripheral blood mononuclear cell is defined as any blood cell with a round nucleus. These blood cells are a critical component in the immune system to fight infection and adapt to intruders. The lymphocyte population consists of CD4+ and CD8+ T cells, B cells and Natural Killer cells, CD14+ Monocytes, and Basophils/Neutrophils/Eosinophils/Dendritic cells. These cells are often extracted from whole blood or from leukopacks using ficoll, a hydrophilic polysaccharide that separates layers of blood, with monocytes and lymphocytes forming a buffy coat under a layer of plasma.Samples from each donor are tested via PCR to confirm non-reactivity. Peripheral blood mononuclear cells are isolated from Type II Diabetes peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh Diabetic Type II PBMCs is available upon request.

HighQC™ Human IPS Cell (IPSC From Fibroblast/ Diabetes Type II/ Episomal)

ABC-SC0010T 1 vial Ask for price
Description: Gentaur is is proud to offer human iPS cell lines derived from the human dermal fibroblasts from patients with Type 2 Diabetes (T2D). The pertinent donor information is available upon request. These iPS cells are established from a single clone and expanded in feeder-free conditions. Normal human iPS cell lines are also available as separate products . We also provide custom iPSC generation and iPSC differentiation services to meet your needs.

Linearity FD Special Diabetes

K889M-5 5 x 2 mL
EUR 374

Human Diabetes Lung Tissue Lysate

IHULGDIBTL100UG each
EUR 1413
Description: Human Diabetes Lung Tissue Lysate

Single Donor Human Diabetes Serum

ISERSDIB each
EUR 209
Description: Single Donor Human Diabetes Serum

HighQC™ Human Bone Marrow Derived Mesenchymal Stem Cell/ Type II Diabetes Patient

ABC-SC0027T 1 vial Ask for price
Description: Human MSCs (Bone Marrow Derived) from a single adult donor clinically diagnosed with Type II Diabetes. The MSCs are compatible with our MSC Expansion Medium for Bone Marrow Derived MSCs.All of the cells provided are tested and are negative for HIV-1, HIV-2, Hepatitis B and Hepatitis C as detected by PCR. The cells are confirmed to be negative for mycoplasma and other detectable microbial contamination.

Human Diabetes Colon Tissue Lysate

IHUCLNDIBTL100UG each
EUR 1413
Description: Human Diabetes Colon Tissue Lysate

Human Diabetes Ileum Tissue Lysate

IHUILMDIBTL100UG each
EUR 1413
Description: Human Diabetes Ileum Tissue Lysate

Single Donor Human Diabetes Plasma

IPLASDIB each
EUR 209
Description: Single Donor Human Diabetes Plasma

Human Diabetes Jejunum Tissue Lysate

IHUJEJDIBTL100UG each
EUR 1413
Description: Human Diabetes Jejunum Tissue Lysate

Human Diabetes Stomach Tissue Lysate

IHUSTDIBTL100UG each
EUR 1413
Description: Human Diabetes Stomach Tissue Lysate

Human Diabetes Duodenum Tissue Lysate

IHUDUODIBTL100UG each
EUR 1413
Description: Human Diabetes Duodenum Tissue Lysate

Human Diabetes Pancreas Tissue Lysate

IHUPCSDIBTL100UG each
EUR 1413
Description: Human Diabetes Pancreas Tissue Lysate

Human Diabetes Esophagus Tissue Lysate

IHUESOPDIBTL100UG each
EUR 1413
Description: Human Diabetes Esophagus Tissue Lysate

Single Donor HumanType I Diabetes Semen

IRHUSSMDIBTI1 each
EUR 842
Description: Single Donor HumanType I Diabetes Semen

Human Diabetes AdiposeVisceral Tissue Lysate

IHUADPTVDIBTL100UG each
EUR 2663
Description: Human Diabetes AdiposeVisceral Tissue Lysate

Human Diabetes Skeletal Muscle Tissue Lysate

IHUSKMDIBTL100UG each
EUR 1413
Description: Human Diabetes Skeletal Muscle Tissue Lysate

Diabetes Drug Leads Bioactive Peptide Library

L-012 160 peptides
EUR 7938

Human Diabetes AdiposeSubcutaneous Tissue Lysate

IHUADPTSDIBTL100UG each
EUR 2663
Description: Human Diabetes AdiposeSubcutaneous Tissue Lysate

Human Diabetes Pancreas Lysate Membrane Fraction

IHUPCSDIBTLM100UG each
EUR 1199
Description: Human Diabetes Pancreas Lysate Membrane Fraction

Linearity FLQ Special Diabetes for Roche Systems

K929M-5 5 x 2 mL
EUR 374

Linearity FLQ Special Diabetes for Abbott Systems

K956M-5 5 x 2 mL
EUR 374

Human Diabetes Skeletal Muscle Lysate Membrane Fraction

IHUSKMDIBTLM100UG each
EUR 1199
Description: Human Diabetes Skeletal Muscle Lysate Membrane Fraction

HighQC™ Induced Pluripotent Stem Cell, From Diabetes (mellitus)

ABC-SC0241 1 vial Ask for price
Description: Diabetes (mellitus), Primary cell type: Fibroblast, Unknown vector detectable; Cells are only guaranteed with purchase of Gentaur Media and Gentaur Extra Cellular Matrix for appropriate cell culture, for 30 days from the date of shipment.

Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad)

MG204351 10 µg Ask for price

Rrad (untagged) - Mouse Ras-related associated with diabetes (Rrad), (10ug)

MC203288 10 µg Ask for price

RRAD (untagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 2

SC117559 10 µg Ask for price

Rrad (untagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug)

RN208148 10 µg Ask for price

Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad)

MR204351 10 µg Ask for price

RRAD (GFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 2

RG202927 10 µg Ask for price

RRAD (Myc-DDK-tagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 2

RC202927 10 µg Ask for price

Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug)

RR208148 10 µg Ask for price

RRAD (untagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 1

SC322965 10 µg Ask for price

Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 2, mGFP tagged

RC202927L4 10 µg Ask for price

Lenti ORF clone of Rrad (mGFP-tagged) - Mouse Ras-related associated with diabetes (Rrad)

MR204351L4 10 µg Ask for price

RRAD (GFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 1

RG225433 10 µg Ask for price

Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 2, Myc-DDK-tagged

RC202927L3 10 µg Ask for price

3`UTR clone of Ras-related associated with diabetes (RRAD) transcript variant 2 for miRNA target validation

SC205326 10 µg Ask for price

Lenti ORF clone of Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad)

MR204351L3 10 µg Ask for price

Lenti ORF clone of Rrad (mGFP-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug)

RR208148L4 10 µg Ask for price

RRAD (Myc-DDK-tagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 1

RC225433 10 µg Ask for price

Lenti ORF clone of Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug)

RR208148L3 10 µg Ask for price

Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 1, mGFP tagged

RC225433L2 10 µg Ask for price

Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 1, mGFP tagged

RC225433L4 10 µg Ask for price

Lenti ORF particles, Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL

MR204351L4V 200 µl Ask for price

Lenti ORF particles, Rrad (GFP-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL

RR208148L4V 200 µl Ask for price

Psoriasis Exosome

P141-PS - Ask for price

Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 1, Myc-DDK-tagged

RC225433L1 10 µg Ask for price

Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 1, Myc-DDK-tagged

RC225433L3 10 µg Ask for price

3`UTR clone of Ras-related associated with diabetes (RRAD) transcript variant 1 for miRNA target validation

SC205328 10 µg Ask for price

Exosome Isolation kit (for serum & plasma -Exosome-RNA-NGS)

P101NGS - Ask for price

Exosome Component 2 (EXOSC2) Antibody

20-abx112411
  • Ask for price
  • Ask for price
  • 150 ul
  • 50 ul

Exosome Component 2 (EXOSC2) Antibody

20-abx125830
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Exosome Component 2 (EXOSC2) Antibody

abx034983-400ul 400 ul
EUR 627.6

Exosome Component 2 (EXOSC2) Antibody

abx034983-80l 80 µl
EUR 343.2

Exosome Component 2 (EXOSC2) Antibody

20-abx003412
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul

Exosome Component 2 (EXOSC2) Antibody

abx232901-100ug 100 ug
EUR 577.2

Exosome Component 2 (EXOSC2) Antibody

abx232902-100ug 100 ug
EUR 661.2

Exosome Component 2 (EXOSC2) Antibody

20-abx172308
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Exosome Component 2 (EXOSC2) Antibody

20-abx176346
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Exosome Component 2 (EXOSC2) Antibody

abx172308-1ml 1 ml
EUR 787.5

Exosome Component 2 (EXOSC2) Antibody

abx176346-1096tests 10 × 96 tests
EUR 750

Exosome Component 2 (EXOSC2) Antibody

abx176346-596tests 5 × 96 tests
EUR 337.5

Exosome Component 2 (EXOSC2) Antibody

abx176346-96tests 96 tests
EUR 275

Exosome Component 2 (EXOSC2) Antibody

abx112411-100l 100 µl
EUR 612.5

Exosome Component 2 (EXOSC2) Antibody

abx034983-100g 100 µg
EUR 281.25

Exosome Component 2 (EXOSC2) Antibody

abx125830-100l 100 µl
EUR 175

Exosome Component 2 (EXOSC2) Antibody

abx125830-1ml 1 ml
EUR 400

Exosome Component 2 (EXOSC2) Antibody

abx125830-200l 200 µl
EUR 275

Exosome Component 2 (EXOSC2) Antibody

abx232901-100g 100 µg
EUR 350

Exosome Component 2 (EXOSC2) Antibody

abx232902-100g 100 µg
EUR 350

Lenti ORF particles, Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL

MR204351L3V 200 µl Ask for price

Lenti ORF particles, Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL

RR208148L3V 200 µl Ask for price

Recombinant Exosome Component 2 (EXOSC2)

RPU57646-100ug 100ug
EUR 470.4

Recombinant Exosome Component 2 (EXOSC2)

RPU57646-1mg 1mg
EUR 2184

Recombinant Exosome Component 2 (EXOSC2)

RPU57646-50ug 50ug
EUR 385

Recombinant Exosome Component 2 (EXOSC2)

RPH822Hu01 10ug
EUR 140

Lenti ORF particles, RRAD (mGFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 2, 200ul, >10^7 TU/mL

RC202927L4V 200 µl Ask for price

Lenti ORF particles, RRAD (Myc-DDK tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 2, 200ul, >10^7 TU/mL

RC202927L3V 200 µl Ask for price

 

, , , , , , , , , , , , , ,

Post navigation

Leave a Reply

Your email address will not be published. Required fields are marked *